Valuation : Alpa Laboratories Limited

Market Cap 978M 10.27M 8.85M 8.31M 7.58M 14.24M 14.35M 98.42M 38.29M 496M 38.58M 37.74M 1.64B P/E 2024
10.4x
P/E 2025 11.2x
Enterprise Value -149M -1.57M -1.35M -1.27M -1.16M -2.18M -2.19M -15.03M -5.85M -75.71M -5.89M -5.76M -251M EV / Sales 2024
0.81x
EV / Sales 2025 0.94x
Free-Float
42.71%
Yield 2024 *
-
Yield 2025 -
08-13 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
07-23 Alpa Laboratories Ltd. Announces Cessation of Ms. Jyoti Jain as an Independent Director, Effective July 21, 2026 CI
07-08 Alpa Laboratories Limited Announces Resignation of Yashoda Patidar as Company Secretary and Compliance Officer, Effective July 26, 2026 CI
05-30 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
04-11 Alpa Laboratories Limited Appoints Ms. Yashoda Patidar as Company Secretary and Compliance Officer, Effective April 11, 2026 CI
02-25 Alpa Laboratories Limited Announces Resignation of Srashti Chopra as Company Secretary and Compliance Officer, Effective March 25, 2026 CI
02-12 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
14/08/25 Alpa Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
01/08/25 Brookfield India Real Estate Trust announced that it expects to receive INR 10.00000015 billion in funding from a group of investors CI
29/05/25 Alpa Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/02/25 Alpa Laboratories Limited Announces Change in Designation of Vitthal Kothana from Non- Executive Director to Executive Director CI
13/02/25 Alpa Laboratories Limited Appoints Srashti Chopra as Company Secretary and Compliance Officer CI
13/02/25 Alpa Laboratories Limited Reports Earnings Results for the Third Quarter Ended December 31, 2024 CI
1 day-1.59%
1 week+0.11%
Current month-7.65%
1 month-7.65%
3 months-11.43%
6 months-2.11%
Current year-20.54%
1 week 60.61
Extreme 60.61
65.3
1 month 60.05
Extreme 60.05
72.5
Current year 46.1
Extreme 46.1
80.08
1 year 46.1
Extreme 46.1
99
3 years 46.1
Extreme 46.1
144.5
5 years 46.1
Extreme 46.1
144.5
10 years 11
Extreme 11
144.5
Manager TitleAgeSince
Chief Executive Officer - 28/05/2016
Director of Finance/CFO 65 -
Director TitleAgeSince
Chairman 83 -
Director/Board Member 77 01/01/1967
Director/Board Member - 28/05/2016
Change 5-day change 1-year change 3-year change Capi.($)
-1.59%+0.11%-35.94%-21.41% 13.87M
-2.81%+0.99%+23.39%+73.53% 50.05B
+1.14%+1.47%+59.54%+123.40% 40.29B
+0.56%+5.80%+17.83%+86.59% 12.17B
+0.98%-1.04%-10.35%+13.15% 11.96B
+0.19%-.--%+29.35%+150.00% 9.25B
+1.75%-2.18%+24.55%+47.76% 7.62B
-0.39%+3.33%+28.21%+222.15% 7.36B
+1.43%+1.70%+50.00%-9.99% 7.21B
-0.84%-2.36%-36.62%+16.04% 5.26B
Average -0.20%+1.17%+15.00%+70.12% 15.12B
Weighted average by Cap. -0.51%+1.77%+29.74%+87.71%

Financials

2024 2025
Net sales 1.09B 11.43M 9.84M 9.24M 8.43M 15.84M 15.96M 109M 42.6M 551M 42.91M 41.98M 1.83B 1.12B 11.82M 10.18M 9.55M 8.72M 16.38M 16.5M 113M 44.05M 570M 44.37M 43.41M 1.89B
Net income 168M 1.76M 1.52M 1.43M 1.3M 2.44M 2.46M 16.89M 6.57M 85.07M 6.62M 6.48M 282M 195M 2.05M 1.76M 1.66M 1.51M 2.84M 2.86M 19.64M 7.64M 98.9M 7.7M 7.53M 327M
Net Debt -876M -9.21M -7.93M -7.44M -6.79M -12.76M -12.86M -88.21M -34.32M -444M -34.57M -33.82M -1.47B -1.13B -11.84M -10.2M -9.57M -8.74M -16.42M -16.54M -113M -44.14M -571M -44.47M -43.5M -1.89B
Logo Alpa Laboratories Limited
Alpa Laboratories Limited is an India-based global pharmaceutical company engaged in manufacturing and selling finished pharmaceutical dosage forms. Its product range includes a variety of ethical, generic, and over the counter (OTC) drugs in various finished dosage forms for both human and veterinary use. Its human use products include capsules, such as Ampicillin Capsule IP/BP, Amoxycillin Trihydrate Capsule IP/BP, Cloxacillin Capsules IP/BP and Piroxicam Capsules IP BP; creams, gels and ointments, which include Lidocaine Hydrochloride Jelly IP/USP, Nitrofurazone Cream USP, Miconazole Cream IP/BP and Clobetasole Ointment/Cream BP; ear and eye drops, such as Benzylpenicillin Inj. IP/BP and Benzathine Penicillin Inj. IP/BP, and tablets, such as Ciprofloxacin Tablet IP / BP, Paracetamol Tablet IP/BP and Tinidazole Tablets IP/BP. Its veterinary products include boluses, such as Alpamin Bolus, Melovin-P Bolus and Alpazole Bolus, and injections, such as Atropine Inj. B.Vet.C and others.
Employees
453
Date Price Change Volume
01/09/26 61.73 -1.59% 15,807
31/08/26 ₹62.73 -1.63% 12,779
28/08/26 ₹63.77 +4.23% 21,708
27/08/26 ₹61.18 -0.44% 7,422
26/08/26 ₹61.45 -1.03% 10,657
  1. Stock Market
  2. Stocks
  3. ALPA Stock